28192171|t|A new light on Alkaptonuria: A Fourier-transform infrared microscopy (FTIRM) and low energy X-ray fluorescence microscopy (LEXRF) correlative study on a rare disease
28192171|a|Alkaptonuria (AKU) is an ultra-rare disease associated to the lack of an enzyme involved in tyrosine catabolism. This deficiency results in the accumulation of homogentisic acid (HGA) in the form of ochronotic pigment in joint cartilage, leading to a severe arthropathy. Secondary amyloidosis has been also unequivocally assessed as a comorbidity of AKU arthropathy. Composition of ochronotic pigment and how it is structurally related to amyloid is still unknown. We exploited Synchrotron Radiation Infrared and X-Ray Fluorescence microscopies in combination with conventional bio-assays and analytical tools to characterize chemical composition and morphology of AKU cartilage. We evinced that AKU cartilage is characterized by proteoglycans depletion, increased Sodium levels, accumulation of lipids in the peri-lacunar regions and amyloid formation. We also highlighted an increase of aromatic compounds and oxygen-containing species, depletion in overall Magnesium content (although localized in the peri-lacunar region) and the presence of calcium carbonate fragments in proximity of cartilage lacunae. We highlighted common features between AKU and arthropathy, but also specific signatures of the disease, like presence of amyloids and peculiar calcifications. Our analyses provide a unified picture of AKU cartilage, shedding a new light on the disease and opening new perspectives. Ochronotic pigment is a hallmark of AKU and responsible of tissue degeneration. Conventional bio-assays have not yet clarified its composition and its structural relationship with amyloids. The present work proposes new strategies for filling the aforementioned gap that encompass the integration of new analytical approaches with standardized analyses.
28192171	15	27	Alkaptonuria	T047	C0002066
28192171	31	68	Fourier-transform infrared microscopy	T059	C0596777
28192171	70	75	FTIRM	T059	C0596777
28192171	81	121	low energy X-ray fluorescence microscopy	T059	C0026022
28192171	123	128	LEXRF	T059	C0026022
28192171	130	147	correlative study	T062	C1511524
28192171	153	165	rare disease	T047	C0678236
28192171	166	178	Alkaptonuria	T047	C0002066
28192171	180	183	AKU	T047	C0002066
28192171	191	209	ultra-rare disease	T047	C0678236
28192171	210	220	associated	T080	C0332281
28192171	228	232	lack	T080	C0332268
28192171	239	245	enzyme	T116,T126	C0014442
28192171	258	277	tyrosine catabolism	T044	C1156678
28192171	284	294	deficiency	T169	C0011155
28192171	310	322	accumulation	T033	C4055506
28192171	326	343	homogentisic acid	T109,T123	C0019881
28192171	345	348	HGA	T109,T123	C0019881
28192171	365	383	ochronotic pigment	UnknownType	C0028818
28192171	387	392	joint	T030	C0022417
28192171	393	402	cartilage	T024	C0007301
28192171	417	423	severe	T080	C0205082
28192171	424	435	arthropathy	T047	C0022408
28192171	437	458	Secondary amyloidosis	T047	C0002726
28192171	473	486	unequivocally	T080	C4053896
28192171	487	495	assessed	T052	C1516048
28192171	501	512	comorbidity	T078	C0009488
28192171	516	519	AKU	T047	C0002066
28192171	520	531	arthropathy	T047	C0022408
28192171	548	566	ochronotic pigment	UnknownType	C0028818
28192171	581	593	structurally	T082	C0678594
28192171	605	612	amyloid	T116,T123	C0002716
28192171	644	665	Synchrotron Radiation	T067	C0599746
28192171	666	674	Infrared	T059	C0596777
28192171	679	710	X-Ray Fluorescence microscopies	T059	C0026022
28192171	744	754	bio-assays	T059	C0005507
28192171	759	769	analytical	T062	C0936012
28192171	792	812	chemical composition	T070	C0243176
28192171	817	827	morphology	T080	C0332437
28192171	831	834	AKU	T047	C0002066
28192171	835	844	cartilage	T024	C0007301
28192171	849	856	evinced	T169	C0205319
28192171	862	865	AKU	T047	C0002066
28192171	866	875	cartilage	T024	C0007301
28192171	896	909	proteoglycans	T116,T123	C0033692
28192171	910	919	depletion	T169	C0333668
28192171	921	944	increased Sodium levels	T033	C0595879
28192171	946	958	accumulation	T033	C4055506
28192171	962	968	lipids	T109	C0023779
28192171	976	996	peri-lacunar regions	T030	C0229984
28192171	1001	1008	amyloid	T116,T123	C0002716
28192171	1009	1018	formation	T169	C1522492
28192171	1043	1051	increase	T169	C0442805
28192171	1055	1073	aromatic compounds	T109	C1510940
28192171	1078	1103	oxygen-containing species	T197	C0684299
28192171	1105	1114	depletion	T169	C0333668
28192171	1126	1135	Magnesium	T123,T196	C0024467
28192171	1136	1143	content	T081	C1264655
28192171	1154	1163	localized	T082	C0392752
28192171	1171	1190	peri-lacunar region	T030	C0229984
28192171	1200	1208	presence	T033	C0150312
28192171	1212	1229	calcium carbonate	T121,T197	C0006681
28192171	1243	1252	proximity	T082	C1514583
28192171	1256	1273	cartilage lacunae	T030	C0225370
28192171	1290	1296	common	T081	C0205214
28192171	1314	1317	AKU	T047	C0002066
28192171	1322	1333	arthropathy	T047	C0022408
28192171	1371	1378	disease	T047	C0012634
28192171	1385	1393	presence	T033	C0150312
28192171	1397	1405	amyloids	T116,T123	C0002716
28192171	1410	1418	peculiar	T033	C0205161
28192171	1419	1433	calcifications	T042	C1533591
28192171	1439	1447	analyses	T062	C0936012
28192171	1477	1480	AKU	T047	C0002066
28192171	1481	1490	cartilage	T024	C0007301
28192171	1520	1527	disease	T047	C0012634
28192171	1540	1543	new	T080	C0205314
28192171	1558	1576	Ochronotic pigment	UnknownType	C0028818
28192171	1594	1597	AKU	T047	C0002066
28192171	1617	1636	tissue degeneration	T042	C1623047
28192171	1651	1661	bio-assays	T059	C0005507
28192171	1689	1700	composition	T070	C0243176
28192171	1709	1719	structural	T082	C0678594
28192171	1720	1732	relationship	T080	C0439849
28192171	1738	1746	amyloids	T116,T123	C0002716
28192171	1752	1759	present	T079	C0521116
28192171	1760	1764	work	T062	C0035168
28192171	1843	1854	integration	T169	C0243126
28192171	1862	1872	analytical	T062	C0936012
28192171	1889	1901	standardized	T080	C1442989
28192171	1902	1910	analyses	T062	C0936012